• CA-074 Me: Advancing Cathepsin B Inhibition in Cell Death Re

  2026-04-21

  Translational researchers face critical challenges in dissecting regulated cell death pathways, especially as new mechanistic insights—from lysosomal permeabilization to necroptosis—reshape our understanding of disease biology. Here, we explore the strategic deployment of CA-074 Me, a potent and selective cathepsin B inhibitor, in state-of-the-art experimental models. We connect recent breakthroughs on MLKL-driven lysosomal membrane permeabilization with practical guidance for optimizing apoptosis and inflammation assays, and provide a forward-looking perspective on how these insights may drive improved disease models and therapeutic discovery.

• Mechanistic Screening Redefined: FDA Libraries for Translati

  2026-04-20

  Explore how the DiscoveryProbe™ FDA-approved Drug Library (SKU: L1021) empowers translational researchers to bridge mechanistic insight and clinical innovation. This thought-leadership article synthesizes cutting-edge mTORC1 pathway sensing (Li et al., 2024) with actionable strategies for high-throughput and high-content drug screening, target identification, and drug repositioning. By integrating evidence from recent studies, competitive analysis, and workflow recommendations, the article provides a strategic blueprint for advancing cancer and neurodegenerative disease research.

• Biomimetic Chromatography Models for Pulmonary Drug Permeabi

  2026-04-20

  This study rigorously evaluates biomimetic open tubular capillary electrochromatography (OT-CEC) and immobilised artificial membrane chromatography (IAM-LC), both coupled with mass spectrometry, for modeling pulmonary drug permeability. The findings clarify the comparative accuracy and mechanistic scope of these MS-compatible techniques, offering researchers enhanced tools for early-stage respiratory drug development and permeability screening.

• Transmission Dynamics of Carbapenemase Genes in CREC During

  2026-04-19

  This study systematically characterizes carbapenemase-encoding genes (CEGs) and their dissemination in carbapenem-resistant Enterobacter cloacae (CREC) isolates from eight hospitals in Guangdong, China, during the COVID-19 pandemic. The findings reveal high rates of multidrug resistance and mobile genetic element-mediated gene transfer, highlighting critical challenges for infection control and experimental resistance modeling.

• LY-411575: Deep Mechanistic Insights for Oncological and Neu

  2026-04-18

  Explore how LY-411575, a potent gamma-secretase inhibitor, uniquely enables next-generation Alzheimer's disease and cancer research. This in-depth article delivers advanced mechanistic understanding and practical assay guidance, surpassing existing resources.

• Myriocin: Translational Leverage in Sphingolipid Metabolism

  2026-04-17

  Explore how Myriocin, a selective serine palmitoyltransferase inhibitor, empowers translational researchers to dissect sphingolipid metabolism and cell cycle regulation. Drawing on recent advances in network pharmacology and mitochondrial biology, this article offers mechanistic clarity, actionable protocol guidance, and strategic insight into Myriocin’s role in cancer research and immunology. The discussion connects preclinical findings, APExBIO’s product leadership, and forward-looking translational opportunities.

• HyperFluor™ 594 Goat Anti-Rabbit IgG: Precision in Immunoflu

  2026-04-16

  The HyperFluor™ 594 Goat Anti-Rabbit IgG (H+L) Antibody from APExBIO delivers high-specificity and reproducibility for immunocytochemistry, immunohistochemistry, and flow cytometry. Its robust fluorophore conjugation and low cross-reactivity enable sensitive, multiplexed detection, empowering translational research in complex biological systems.

• NSC-23766: Optimizing Rac GTPase Inhibition for Cancer Resea

  2026-04-15

  NSC23766 trihydrochloride, a selective Rac GTPase inhibitor from APExBIO, streamlines apoptosis induction and cell cycle modulation in cancer and vascular assays. This article unpacks applied workflows, troubleshooting tactics, and protocol innovations for maximizing reproducibility and data clarity when targeting the Rac1 signaling pathway.

• SREBP-1c Disrupts ULK1 Sulfhydration and Autophagy in NAFLD

  2026-04-14

  Nguyen et al. (2021) uncover how high-fat-diet-induced SREBP-1c suppresses hepatic autophagy by interfering with ULK1 sulfhydration, thereby promoting lipid accumulation in the liver. These mechanistic insights reveal new regulatory nodes in the pathogenesis of non-alcoholic fatty liver disease (NAFLD), with implications for targeting protein phosphorylation and autophagy in metabolic research.

• DAPI (hydrochloride): Technical Guidance for DNA Staining Wo

  2026-04-13

  DAPI (hydrochloride) provides a reliable, DNA-specific fluorescent probe for chromosome staining, cell cycle analysis, and DNA quantitation in fixed and live cell workflows. It addresses the need for high-sensitivity DNA visualization, particularly in histochemistry and flow cytometry. Researchers should note its limited permeability in live cells and avoid ethanol as a solvent.

• G007-LK Tankyrase 1/2 Inhibitor: Mechanistic Insights & Assa

  2026-04-13

  Explore the unique mechanisms and advanced assay applications of the G007-LK tankyrase 1/2 inhibitor. This article offers a rigorous, evidence-backed analysis for Wnt/β-catenin pathway modulation and APC mutation colorectal cancer research.

• AO/PI Double Staining Kit: Precision in Cell Viability Assay

  2026-04-12

  The AO/PI Double Staining Kit delivers rapid and reliable differentiation of viable, apoptotic, and necrotic cells in complex systems such as glioma organoids. Its dual-dye approach empowers researchers to evaluate cell death mechanisms with high clarity, supporting both routine and advanced workflows.

• MLKL Polymerization Drives Necroptosis via Lysosomal Catheps

  2026-04-12

  This study uncovers how MLKL polymerization on lysosomal membranes induces lysosomal membrane permeabilization (LMP), leading to the cytosolic release of cathepsin B, which is critical for necroptosis execution. Chemical inhibition or knockdown of cathepsin B significantly protects cells from necroptotic death, highlighting a pivotal mechanistic axis with translational implications.

• PNU 74654: Advanced Wnt Signaling Pathway Inhibitor Workflow

  2026-04-11

  PNU 74654 enables precise, high-purity inhibition of the Wnt/β-catenin pathway for dissecting cell proliferation and differentiation in cancer and stem cell research. This article translates recent mechanistic insights into actionable protocols, advanced applications, and troubleshooting strategies, delivering superior reproducibility for in vitro studies.

• CA-074: Cathepsin B Inhibitor Workflows for Necroptosis and

  2026-04-11

  CA-074 offers reliable, nanomolar-selective cathepsin B inhibition for dissecting regulated cell death and metastatic pathways. This article gives practical, data-driven guidance for experimental design, troubleshooting, and maximizing insight in cancer, neurodegeneration, and immune modulation models.

15586 records 1/1040 page Next 12345 下5页 Last page